Augusto di Castelnuovo

Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus.

R. Liani, T. Ueland, P. Simeone, 2024, Cardiovascular diabetology.